Parexel opens new European coordination hub and distribution center in Germany

14 November 2014
parexel-big

Leading global biopharma services provider Parexel (Nasdaq: PRXL) has opened its new European Coordination Hub and Distribution Center in Berlin-Schönefeld, Germany. The new facility expands Parexel’s capacity to provide comprehensive clinical trial supply and logistics services for local, regional and global trial requirements from clients, such as synchronized coordination of supplies, ancillary supplies and central laboratory services.

It measures more than 65,000 cubic meters in storage space, offers lab-kit assembly and provides storage and distribution of ancillary materials.

Mark Goldberg, president and chief operating officer of Parexel, said: “To safely and efficiently conduct clinical trials, our customers need highly specialized clinical supply and logistics services for studies that can span dozens of countries and hundreds of sites around the world. Our new European distribution center reflects a commitment to simplify the important end-to-end supply-management aspect of the drug-development journey.”

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical